Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Featured trial
A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of atogepant for the prevention of chronic migraines (PROGRESS)

To evaluate the safety and tolerability of atogepant 30 mg twice per day (BID) and 60 mg once daily for the prevention of chronic migraine (CM).  

  • 43 views
  • 10 May, 2019
  • 1 location
Featured trial
Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

We are seeking adult participants for a new clinical research study to evaluate the effectiveness of an investigational drug as a preventative treatment for migraines.

  • 0 views
  • 31 Aug, 2021
  • 1 location
Featured trial
Do you organize your life around chronic migraine pain?

Do you organize your life around chronic migraine pain?

  • 788 views
  • 08 Nov, 2020
  • 2 locations
Featured trial
Do you organize your life around chronic migraine pain?

Do you organize your life around chronic migraine pain?

  • 306 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine

A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine

  • 310 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)

This is a 20-week study to evaluate the efficacy, safety, and tolerability of once-daily oral Atogepant for the prevention of migraine in participants with episodic migraine. Treatment groups include 30mg twice daily, 60mg once daily, and placebo. This study will consist of a 4-week screening and baseline period, a 12-week …

  • 282 views
  • 03 Aug, 2020
  • 1 location
Featured trial
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study

This study will help us learn more about a study drug called galcanezumab. We are testing this study drug to find out if it is safe and effective at helping adolescents who have chronic migraine

chronic migraine
migraine in children
migraine
  • 1 views
  • 27 Jan, 2021
  • 1 location
Featured trial
Migraine

Migraines are more than just headaches. They are debilitating and painful. In addition to headache, migraine symptoms may include nausea, vomiting and sensitivity to light and sound.   Migraine is a common cause of headaches in adults. Population-based studies indicate that between 12 - 16 % of people suffer from …

  • 6 views
  • 30 Jul, 2021
  • 1 location
None
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary

  • 0 views
  • 24 Nov, 2021
  • 99 locations
None
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

categorized according to the frequency of attacks as episodic migraine (EM) or chronic migraine (CM). This study will assess the effects of BOTOX in preventing migraine in adult participants with EM.

  • 0 views
  • 01 Dec, 2021
  • 123 locations